| Trial ID: | L2887 |
| Source ID: | NCT01250340
|
| Associated Drug: |
Aspirin
|
| Title: |
Type 2 Diabetes Mellitus and Atherosclerosis
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Aspirin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Changes of isoprostanes after study drug administration., Mearuring levels of isoprostanes to understand if isoprostanes could play a crucial role in thrombus formation, independently from Aspirin mediated COX-1 inhibition, supporting their role in the phenomenon of the so call "aspirin resistance" in the setting of T2DM., 3 and 30 days |
|
| Sponsor/Collaborators: |
Sponsor: University of Roma La Sapienza | Collaborators: University of Rome Tor Vergata
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-08
|
| Completion Date: |
2012-12
|
| Results First Posted: |
|
| Last Update Posted: |
2012-11-28
|
| Locations: |
Sapienza Università di Roma, Rome, 00161, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT01250340
|
